Logo image of MMD

NYLI MACKAY DT MUNI OPPO FND (MMD) Stock Price, Quote, News and Overview

NYSE:MMD - New York Stock Exchange, Inc. - US56064K1007 - Currency: USD

14.51  +0.01 (+0.07%)

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to MMD. MMD was compared to 0 industry peers in the Unkown industry. MMD has a bad profitability rating. Also its financial health evaluation is rather negative. MMD does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

MMD had positive earnings in the past year.
In the past year MMD had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: MMD reported negative net income in multiple years.
Of the past 5 years MMD 4 years had a positive operating cash flow.
MMD Yearly Net Income VS EBIT VS OCF VS FCFMMD Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M

1.2 Ratios

Industry RankSector Rank
ROA 4.02%
ROE 5.69%
ROIC 1.99%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
MMD Yearly ROA, ROE, ROICMMD Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 10 -10

1.3 Margins

In the last couple of years the Profit Margin of MMD has declined.
In the last couple of years the Operating Margin of MMD has declined.
In the last couple of years the Gross Margin of MMD has declined.
Industry RankSector Rank
OM 57.14%
PM (TTM) 91.86%
GM 59.52%
OM growth 3Y-11.55%
OM growth 5Y-5%
PM growth 3Y-36.09%
PM growth 5Y-11.32%
GM growth 3Y-11.9%
GM growth 5Y-5.23%
MMD Yearly Profit, Operating, Gross MarginsMMD Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100 -100

2

2. Health

2.1 Basic Checks

MMD has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
MMD Yearly Shares OutstandingMMD Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 5M 10M 15M 20M 25M
MMD Yearly Total Debt VS Total AssetsMMD Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 200M 400M 600M 800M

2.2 Solvency

Based on the Altman-Z score of 0.51, we must say that MMD is in the distress zone and has some risk of bankruptcy.
The Debt to FCF ratio of MMD is 0.89, which is an excellent value as it means it would take MMD, only 0.89 years of fcf income to pay off all of its debts.
MMD has a Debt/Equity ratio of 0.41. This is a healthy value indicating a solid balance between debt and equity.
Although MMD does not score too well on debt/equity it has very limited outstanding debt, which is well covered by the FCF. We will not put too much weight on the debt/equity number as it may be because of low equity, which could be a consequence of a share buyback program for instance. This needs to be investigated.
Industry RankSector Rank
Debt/Equity 0.41
Debt/FCF 0.89
Altman-Z 0.51
ROIC/WACCN/A
WACCN/A
MMD Yearly LT Debt VS Equity VS FCFMMD Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M

2.3 Liquidity

A Current Ratio of 0.09 indicates that MMD may have some problems paying its short term obligations.
A Quick Ratio of 0.09 indicates that MMD may have some problems paying its short term obligations.
Industry RankSector Rank
Current Ratio 0.09
Quick Ratio 0.09
MMD Yearly Current Assets VS Current LiabilitesMMD Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 100M 200M 300M

2

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 80.00% over the past year.
Measured over the past years, MMD shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -19.36% on average per year.
MMD shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 10.44%.
The Revenue has been decreasing by -8.22% on average over the past years.
EPS 1Y (TTM)80%
EPS 3Y-43.46%
EPS 5Y-19.36%
EPS Q2Q%450%
Revenue 1Y (TTM)10.44%
Revenue growth 3Y-10.36%
Revenue growth 5Y-8.22%
Sales Q2Q%12.74%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
MMD Yearly Revenue VS EstimatesMMD Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M

1

4. Valuation

4.1 Price/Earnings Ratio

MMD is valuated reasonably with a Price/Earnings ratio of 11.52.
MMD is valuated cheaply when we compare the Price/Earnings ratio to 27.46, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 11.52
Fwd PE N/A
MMD Price Earnings VS Forward Price EarningsMMD Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF 1.27
EV/EBITDA N/A
MMD Per share dataMMD EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

4

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 4.55%, MMD is a good candidate for dividend investing.
MMD's Dividend Yield is rather good when compared to the S&P500 average which is at 2.34.
Industry RankSector Rank
Dividend Yield 4.55%

5.2 History

MMD has paid a dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
MMD Yearly Dividends per shareMMD Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6 0.8 1

5.3 Sustainability

73.20% of the earnings are spent on dividend by MMD. This is not a sustainable payout ratio.
DP73.2%
EPS Next 2YN/A
EPS Next 3YN/A
MMD Yearly Income VS Free CF VS DividendMMD Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M
MMD Dividend Payout.MMD Dividend Payout, showing the Payout Ratio.MMD Dividend Payout.PayoutRetained Earnings

NYLI MACKAY DT MUNI OPPO FND

NYSE:MMD (7/21/2025, 6:40:00 PM)

14.51

+0.01 (+0.07%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners77.73%
Inst Owner Change0.25%
Ins Owners0.04%
Ins Owner Change0%
Market Cap272.50M
Analysts0
Price TargetN/A
Short Float %0.19%
Short Ratio0.64
Dividend
Industry RankSector Rank
Dividend Yield 4.55%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP73.2%
Div Incr Years0
Div Non Decr Years0
Ex-Date09-15 2025-09-15 (0.06)
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 11.52
Fwd PE N/A
P/S 9.4
P/FCF 1.27
P/OCF 1.27
P/B 0.58
P/tB 0.58
EV/EBITDA N/A
EPS(TTM)1.26
EY8.68%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)11.45
FCFY78.9%
OCF(TTM)11.45
OCFY78.9%
SpS1.54
BVpS24.92
TBVpS24.92
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 4.02%
ROE 5.69%
ROCE 3.54%
ROIC 1.99%
ROICexc 2.01%
ROICexgc 2.01%
OM 57.14%
PM (TTM) 91.86%
GM 59.52%
FCFM 741.38%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-11.55%
OM growth 5Y-5%
PM growth 3Y-36.09%
PM growth 5Y-11.32%
GM growth 3Y-11.9%
GM growth 5Y-5.23%
F-Score8
Asset Turnover0.04
Health
Industry RankSector Rank
Debt/Equity 0.41
Debt/FCF 0.89
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage 250
Cash Conversion N/A
Profit Quality 807.06%
Current Ratio 0.09
Quick Ratio 0.09
Altman-Z 0.51
F-Score8
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)80%
EPS 3Y-43.46%
EPS 5Y-19.36%
EPS Q2Q%450%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)10.44%
Revenue growth 3Y-10.36%
Revenue growth 5Y-8.22%
Sales Q2Q%12.74%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y49.28%
EBIT growth 3Y-20.71%
EBIT growth 5Y-12.81%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y464.16%
FCF growth 3Y13.23%
FCF growth 5Y65.96%
OCF growth 1Y464.16%
OCF growth 3Y13.23%
OCF growth 5Y65.96%